Skip to main content

Peer Review reports

From: Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

Original Submission
22 Jul 2016 Submitted Original manuscript
12 Sep 2016 Reviewed Reviewer Report - CL Phillips
31 Oct 2016 Reviewed Reviewer Report - Mary Barbe
18 Nov 2016 Author responded Author comments - Tero Puolakkainen
Resubmission - Version 2
18 Nov 2016 Submitted Manuscript version 2
10 Dec 2016 Author responded Author comments - Tero Puolakkainen
Resubmission - Version 3
10 Dec 2016 Submitted Manuscript version 3
Publishing
14 Dec 2016 Editorially accepted
19 Jan 2017 Article published 10.1186/s12891-016-1366-3

You can find further information about peer review here.

Back to article page